Pineapple compound could potentially be anti-SARS-CoV-2 agent

In a recent study, scientists demonstrated that the pineapple-derived jacalin-related lectin (AcmJRL/AnLec) could be an anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) agent.

With approximately 529 million global SARS-CoV-2 cases identified to date, the current CoV disease 2019 (Covid-19) pandemic has emerged as one of the substantially challenging global health risks. Complementary to COVID-19 vaccines, innovative medications have been the topic of studies and development. SARS-CoV-2's highly glycosylated spike (S) protein is a primary focus for antiviral medicines since it aids in infection.

The AcmJRL is found in substantial amounts in the drug bromelain and is known to attach mannosides. Further, an Ananas comosus (pineapple) stem extract, bromelain, is an authorized fibrinolytic, anti-inflammatory, and anti-edematous agent used to treat trauma-triggered swelling.


Publication date:

Receive the daily newsletter in your email for free | Click here

Other news in this sector:

Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber